Your browser doesn't support javascript.
Time-dependent changes in the clinical characteristics and prognosis of hospitalized COVID-19 patients in Wuhan, China: A retrospective study.
Wang, Menglong; Zhang, Jishou; Ye, Di; Wang, Zhen; Liu, Jianfang; He, Hua; Shen, Bo; Luo, Zhen; Ye, Jing; Xu, Yao; Zhao, Mengmeng; Liu, Mingxiao; Zhang, Pingan; Gu, Jian; Pan, Wei; Liu, Menglin; Li, Dan; Wan, Jun.
  • Wang M; Department of Cardiology, Renmin Hospital of Wuhan University, China; Cardiovascular Research Institute, Wuhan University, China; Hubei Key Laboratory of Cardiology, China.
  • Zhang J; Department of Cardiology, Renmin Hospital of Wuhan University, China; Cardiovascular Research Institute, Wuhan University, China; Hubei Key Laboratory of Cardiology, China.
  • Ye D; Department of Cardiology, Renmin Hospital of Wuhan University, China; Cardiovascular Research Institute, Wuhan University, China; Hubei Key Laboratory of Cardiology, China.
  • Wang Z; Department of Cardiology, Renmin Hospital of Wuhan University, China; Cardiovascular Research Institute, Wuhan University, China; Hubei Key Laboratory of Cardiology, China.
  • Liu J; Department of Cardiology, Renmin Hospital of Wuhan University, China; Cardiovascular Research Institute, Wuhan University, China; Hubei Key Laboratory of Cardiology, China.
  • He H; Department of Medical Affaires, Renmin Hospital of Wuhan University, China.
  • Shen B; Department of Medical Affaires, Renmin Hospital of Wuhan University, China.
  • Luo Z; Department of Cardiology, Renmin Hospital of Wuhan University, China; Cardiovascular Research Institute, Wuhan University, China; Hubei Key Laboratory of Cardiology, China.
  • Ye J; Department of Cardiology, Renmin Hospital of Wuhan University, China; Cardiovascular Research Institute, Wuhan University, China; Hubei Key Laboratory of Cardiology, China.
  • Xu Y; Department of Cardiology, Renmin Hospital of Wuhan University, China; Cardiovascular Research Institute, Wuhan University, China; Hubei Key Laboratory of Cardiology, China.
  • Zhao M; Department of Cardiology, Renmin Hospital of Wuhan University, China; Cardiovascular Research Institute, Wuhan University, China; Hubei Key Laboratory of Cardiology, China.
  • Liu M; Medical Quality Management Office, Renmin Hospital of Wuhan University, China.
  • Zhang P; Department of Clinical Laboratory, Renmin Hospital of Wuhan University, China.
  • Gu J; Department of Clinical Laboratory, Renmin Hospital of Wuhan University, China.
  • Pan W; Department of Cardiology, Renmin Hospital of Wuhan University, China; Cardiovascular Research Institute, Wuhan University, China; Hubei Key Laboratory of Cardiology, China.
  • Liu M; Department of Emergency, Renmin Hospital of Wuhan University, China.
  • Li D; Department of Pediatrics, Renmin Hospital of Wuhan University, China.
  • Wan J; Department of Cardiology, Renmin Hospital of Wuhan University, China; Cardiovascular Research Institute, Wuhan University, China; Hubei Key Laboratory of Cardiology, China. Electronic address: wanjun@whu.edu.cn.
Clin Chim Acta ; 510: 220-227, 2020 Nov.
Article in English | MEDLINE | ID: covidwho-634044
ABSTRACT
Cases of coronavirus disease 2019 (COVID-19) have been breaking out around the world recently. However, the dynamic changes in the clinical symptoms and prognosis of COVID-19 patients remain unknown. According to the onset time of initial clinical symptoms, 843 COVID-19 patients admitted between Jan 22 and Feb 14, 2020 were divided into three groups group A (Jan 21 to Jan 25, n = 324), group B (Jan 26 to Jan 31, n = 358) and group C (Feb 1 to Feb 10, n = 161). Data on the demographics, symptoms, first laboratory results, treatments and outcomes (within 12 days of hospitalization) were collected. The results showed that the median duration from symptom onset to admission shortened over time (13, 10 and 5 days, respectively, p < 0.05). Fewer patients had fever symptoms and bilateral pneumonia in group C than in the group A and B. Laboratory results showed that white blood cell, neutrophil, and platelet counts, lactic acid and D-dimer levels were lower, while lymphocyte, CD3, and CD8 counts were higher in group C. In addition, group C had more mild-moderate cases and fewer severe cases than the other two groups. More importantly, the incidence of complications (18.5%, 14.2% and 11.2%, respectively, p < 0.05) and all-cause mortality (11.7%, 8.4%, and 5.6%, respectively, p < 0.05) decreased over time. The clinical characteristics and prognosis of COVID-19 patients changed over time. Improved prognosis was found at a later stage.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Hospitalization Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: Clin Chim Acta Year: 2020 Document Type: Article Affiliation country: J.cca.2020.06.051

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Hospitalization Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: Clin Chim Acta Year: 2020 Document Type: Article Affiliation country: J.cca.2020.06.051